Asciminib 40 mg Tab,Dasatinib 50 mg Tab,Acalabrutinib 100 mg Tab,Sofosbuvir 400 mg and Velpatasavir
Other · open
Key facts
- Closing date: 21 Jul 2026
- Status: open
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
Commercial terms
- Make in India (MII): No
- MSE preference: No
1 tender document(s) available — sign up to download.